The biological activity of macrophages in health and disease;Aktywność biologiczna makrofagów w zdrowiu i chorobie

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 66, Issue , 2012, Pages 507-520

  Nazimek, Katarzyna ^a   Bryniarski, Krzysztof ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Immunomodulation; M1 phenotype; M2 phenotype; Macrophages; Tams

Indexed keywords

EID: 84867975390     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1004080     Document Type: Review

References (90)

1. Atochina O., Da'dara A. A., Walker M., Harn D. A.: The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo. Immunology, 2008;125:111-121
2. Bae Y. S., Lee J. H., Choi S. H., Kim S., Almazan F., Witztum J. L., Miller Y. I.: Macrophages generate reactive oxygen species in response to minimally oxidized low-density protein: Toll-like receptor4-and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ. Res., 2009;104:210-218
3. Bradshaw E. M., Raddassi K., Elyaman W., Orban T., Gottlieb P. A., Kent S. C., Hafler D. A.: Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J. Immunol., 2009;183:4432-4439
4. Bryniarski K., Szczepanik M., Maresz K., Ptak M., Ptak W.: Subpopulations of mouse testicular macrophages and their immunoregulatory function. Am. J. Reprod. Immunol., 2004;52:27-35
5. Bryniarski K., Szczepanik M., Ptak M., Ptak W.: Modulation of testicular macrophage activity by collagenase. Folia Histochem. Cytobiol., 2005;43:37-41
6. Bryniarski K., Szczepanik M., Ptak M., Ptak W.: The influence of collagenase treatment on the production of TNF-α, IL-6 and IL-10 by testicular macrophages. J. Immunol. Methods, 2005;301:186-189
7. Buhtoiarov I. N., Sondel P. M., Wigginton J. M., Buhtoiarova T. N., Yanke E. M., Mahvi D. A., Rakhmilevich A. L.: Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages. Immunology, 2011;132:226-239
8. Butchar J. P., Mehta P., Justiniano S. E., Guenterberg K. D., Kondadasula S. V., Mo X., Chemudupati M., Kanneganti T. D., Amer A., Muthusamy N., Jarjoura D., Marsh C. B., Carson W. E. III, Byrd J. C., Tridandapani S.: Reciprocal regulation of activating and inhibitory Fcγ receptors by TLR7/8 activation: implications for tumor immunotherapy. Clin. Cancer Res., 2010;16:2065-2075
9. Cashman J. R., Ghirmai S., Abel K. J., Fiala M.: Immune defects in Alzheimer's disease: new medications development. BMC Neuroscience, 2008;9(Suppl.2):S13
10. Chawla A., Nguyen K. D., Goh Y. P.: Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol., 2011;11:738-749
11. Claria J., Gonzáles-Périz A., López-Vicario C., Rius B., Titos E.: New insights into the role of macrophages in adipose tissue inflammation and fatty liver disease: modulation by endogenous omega-3 fatty acid-derived lipid mediators. Front. Immunol., 2011;2:49
12. Coffelt S. B., Hughes R., Lewis C. E.: Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim. Biophys. Acta, 2009;1796:11-18
13. Condamine T., Gabrilovich D. I.: Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol., 2011;32:19-25
14. Duan L., Ren Y.: Role of Notch signaling in osteoimmunology - from the standpoint of osteoclast differentiation. Eur. J. Orthod., 2012 (w druku)
15. Eleftheriadis T., Antoniadi G., Liakopoulos V., Stefanidis I., Galaktidou G.: Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients. Iran. J. Kidney Dis., 2012;6:129-135
16. Fairweather D., Cihakova D.: Alternatively activated macrophages in infection and autoimmunity. J. Autoimmun., 2009;33:222-230
17. Fiala M., Liu P. T., Espinosa-Jeffrey A., Rosenthal M. J., Bernard G., Ringman J. M., Sayre J., Zhang L., Zaghi J., Dejbakhsh S., Chiang B., Hui J., Mahanian M., Baghaee A., Hong P., Cashman J.: Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci. USA, 2007;104:12849-12854
18. Fitzpatrick A. M., Teague W. G., Burwell L., Brown M. S., Brown L. A., NIH/NHLBI Severe Asthma Research Program: Glutathione oxidation is associated with airway macrophage functional impairment in children with severe asthma. Pediatr. Res., 2011;69:154-159
19. Fujisaka S., Usui I., Kanatani Y., Ikutani M., Takasaki I., Tsuneyama K., Tabuchi Y., Bukhari A., Yamazaki Y., Suzuki H., Senda S., Aminuddin A., Nagai Y., Takatsu K., Kobayashi M., Tobe K.: Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice. Endocrinology, 2011;152:1789-1799
20. Gabrusiewicz K., Ellert-Miklaszewska A., Lipko M., Sielska M., Frankowska M., Kamińska B.: Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS One, 2011;6:e23902
21. Gantke T., Sriskantharajah S., Ley S. C.: Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase. Cell Res., 2011;21:131-145
22. Gao D., Bing C.: Macrophage-induced expression and release of matrix metalloproteinase 1 and 3 by human preadipocytes is mediated by IL-1β via activation of MAPK signaling. J. Cell. Physiol., 2011;226:2869-2880
23. Gonzalez N. A., Bensinger S. J., Hong C., Beceiro S., Bradley M. N., Zelcer N., Deniz J., Ramirez C., Diaz M., Gallardo G., de Galarreta C. R., Salazar J., Lopez F., Edwards P., Parks J., Andujar M., Tontonoz P., Castrillo A.: Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity, 2009;31:245-258
24. Hagemann T., Biswas S. K., Lawrence T., Sica A., Lewis C. E.: Regulation of macrophage function in tumors: the multifaceted role of NF-κB. Blood, 2009;113:3139-3146
25. Hagemann T., Lawrence T., McNeish I., Charles K. A., Kulbe H., Thompson R. G., Robinson S. C., Balkwill F. R.: "Re-educating" tumor-associated macrophages by targeting NF-κB. J. Exp. Med., 2008;205:1261-1268
26. Hansson G. K.: Immune mechanism in atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2001;21:1876-1890
27. Hao J. S., Shan B. E.: Immune enhancement and anti-tumour activity of IL-23. Cancer Immunol. Immunother., 2006;55:1426-1431
28. Harel-Adar T., Mordechai T. B., Amsalem Y., Feinberg M. S., Leor J., Cohen S.: Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc. Natl. Acad. Sci. USA, 2011;108:1827-1832
29. Hiwatashi K., Tamiya T., Hasegawa E., Fukaya T., Hashimoto M., Kakoi K., Kashiwagi I., Kimura A., Inoue N., Morita R., Yasukawa H., Yoshimura A.: Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction. Cancer Lett., 2011;308:172-180
30. Hultén L. M., Ullström C., Krettek A., van Reyk D., Marklund S. L., Dahlgren C., Wiklund O.: Human macrophages limit oxidation products in low density lipoprotein. Lipids Health Dis., 2005;4:6
31. Inoue M., Itoh H., Tanaka T., Chun T. H., Doi K., Fukunaga Y., Sawada N., Yamshita J., Masatsugu K., Saito T., Sakaguchi S., Sone M., Yamahara K., Yurugi T., Nakao K.: Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ. Arterioscler. Thromb. Vasc. Biol., 2001;21:560-566
32. Ivashkiv L. B., Zhao B., Park-Min K. H., Takami M.: Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8. Ann. N. Y. Acad. Sci., 2011;1237:88-94
33. Iwasaki A., Medzhitov R.: Regulation of adaptive immunity by the innate immune system. Science, 2010;327:291-295
34. Jiang X., Chen Z. J.: The role of ubiquitylation in immune defence and pathogen evasion. Nat. Rev. Immunol., 2011;12:35-48
35. Johnson E. E., Buhtoiarov I. N., Baldeshwiler M. J., Felder M. A., Van Rooijen N., Sondel P. M., Rakhmilevich A. L.: Enhanced T cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in mice. J. Immunother., 2011;34:76-84
36. Kalinski P.: Regulation of immune responses by prostaglandin E2. J. Immunol., 2012;188:21-28
37. Kennedy A., Fearon U., Veale D. J., Godson C.: Macrophages in synovial inflammation. Front. Immunol., 2011;2:52
38. Kennedy D. J., Kuchibhotla S., Westfall K. M., Silverstein R. L., Morton R. E., Febbraio M.: A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc. Res., 2011;89:604-613
39. Kirkiles-Smith N. C., Harding M. J., Shepherd B. R., Fader S. A., Yi T., Wang Y., McNiff J. M., Snyder E. L., Lorber M. I., Tellides G., Pober J. S.: Development of a humanized mouse model to study the role of macrophages in allograft injury. Transplantation, 2009;87:189-197
40. Klotz K., Ziegler T., Figueiredo A. S., Rausch S., Hepworth M. R., Obsivac N., Sers C., Lang R., Hammerstein P., Lucius R., Hartmann S.: A helminth immunomodulator exploits host signaling events to regulate cytokine production in macrophages. PLoS Pathog., 2011;7:e1001248
41. Kogawa M., Findlay D. M., Anderson P. H., Ormsby R., Vincent C., Morris H. A., Atkins G. J.: Osteoclastic metabolism of 25 (OH) - Vitamin D3: a potential mechanism for optimization of bone resorption. Endocrinology, 2010;151:4613-4625
42. Lakhan S. E., Kirchgessner A.: Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J. Transl. Med., 2011;9:129
43. Li H., Ciric B., Yang J., Xu H., Fitzgerald D. C., Elbehi M., Fonseca-Kelly Z., Yu S., Zhang G. X., Rostami A.: Intravenous tolerance modulates macrophage classical activation and antigen presentation in experimental autoimmune encephalomyelitis. J. Neuroimmunol., 2009;208:54-60
44. Li X., Speer M. Y., Yang H., Bergen J., Giachelli C. M.: Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin. Arterioscler. Thromb. Vasc. Biol., 2010;30:321-326
45. Lichtenstein L., Mattijssen F., de Wit N. J., Georgiadi A., Hooiveld G. J., van der Meer R., He Y., Qi L., Köster A., Tamsma J. T., Tan N. S., Muller M., Kersten S.: Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab., 2010;12:580-592
46. Luo Y., Han R., Evanoff D. P., Chen X.: Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells. Clin. Exp. Immunol., 2010;160:359-368
47. Luo Y., Knudson M. J.: Mycobacterium bovis Bacillus Calmette- Guérininduced macrophage cytotoxicity against bladder cancer cells. Clin. Develop. Immunol., 2010;2010:357591
48. Mancino A., Lawrence T.: Nuclear factor-κB and tumor-associated macrophages. Clin. Cancer Res., 2010;16:784-789
49. Mantovani A., Sica A.: Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol., 2010;22:231-237
50. Marino S., Myers A., Flynn J. L., Kirschner D. E.: TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next generation two-compartmental model. J. Theor. Biol., 2010;265:586-598
51. Miyake Y., Asano K., Kaise H., Uemura M., Nakayama M., Tanaka M.: Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cells-associated antigens. J. Clin. Invest., 2007;117:2268-2278
52. Mott K. R., Gate D., Zandian M., Allen S. J., Rajasagi N. K., van Rooijen N., Chen S., Arditi M., Rouse B. T., Flavell R. A., Town T., Ghiasi H.: Macrophage IL-12p70 signaling prevents HSV-1-induced CNS autoimmunity triggered by autoaggressive CD4+ Tregs. Invest. Ophthalmol. Vis. Sci., 2011;52:2321-2333
53. Mukundan L., Odegaard J. I., Morel C. R., Heredia J. E., Mwangi J. W., Ricardo-Gonzales R. R., Goh Y. P., Eagle A. R., Dunn S. E., Awakuni J. U., Nguyen K. D., Steinman L., Michie S. A., Chawla A.: PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat. Med., 2009;15:1266-1272
54. Murray P. J., Wynn T. A.: Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol., 2011;89:557-563
55. Murray P. J., Wynn T. A.: Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol., 2011;11:723-737
56. Nagamatsu T., Schust D. J.: The contribution of macrophages to normal and pathological pregnancies. Am. J. Reprod. Immunol., 2010;63:460-471
57. Németh K., Leelahavanichkul A., Yuen P. S., Mayer B., Parmelee A., Doi K., Robey P. G., Leelahavanichkul K., Koller B. H., Brown J. M., Hu X., Jelinek I., Star R. A., Mezey E.: Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med., 2009;15:42-49
58. Nguyen K. D., Qiu Y., Cui X., Goh Y. P., Mwangi J., David T., Mukundan L., Brombacher F., Locksley R. M., Chawla A.: Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature, 2011;480:104-108
59. Nickel T., Hanssen H., Emslander I., Drexel V., Hertel G., Schmidt-Trucksäss A., Summo C., Sisic Z., Lambert M., Hoster E., Halle M., Weis M.: Immunomodulatory effects of aerobic training in obesity. Mediators Inflammat., 2011;2011:308965
60. Nucera S., Biziato D., De Palma M.: The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int. J. Dev. Biol., 2011;55:495-503
61. Ouchi N., Parker J. L., Lugus J. J., Walsh K.: Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol., 2011;11:85-97
62. Pina Y., Boutrid H., Murray T. G., Jager M. J., Cebulla C. M., Schefler A., Ly L. V., Alegret A., Celdran M., Feuer W., Jockovich M. E.: Impact of tumor-asssociated macrophages in LHBETATAG mice on retinal tumor progression: relation to macrophage subtype. Invest. Ophthalmol. Vis. Sci., 2010;51:2671-2677
63. Porta C., Riboldi E., Sica A.: Mechanisms linking pathogens-associated inflammation and cancer. Cancer Lett., 2011;305:250-262
64. Qin Z.: The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis, 2012;221:2-11
65. Shanker A.: Adaptive control of innate immunity. Immunol. Lett., 2010;131:107-112
66. Shechter R., London A., Varol C., Raposo C., Cusimano M., Yovel G., Rolls A., Mack M., Pluchino S., Martino G., Jung S., Schwartz M.: Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med., 2009;6:e1000113
67. Shida K., Kiyoshima-Shibata J., Kaji R., Nagaoka M., Nanno M.: Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through Toll-like receptor 2-dependent and independent mechanisms. Immunology, 2009;128(Suppl.1):e858-e869
68. Shida K., Nanno M., Nagata S.: Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes, 2011;2:109-114
69. Sia C., Hänninen A.: Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes. Rev. Diabet. Stud., 2010;7:6-14
70. Sica A., Porta C., Riboldi E., Locati M.: Convergent pathways of macrophage polarization: the role of B cells. Eur. J. Immunol., 2010;40:2131-2133
71. Sierra-Filardi E., Puig-Kröger A., Blanco F. J., Nieto C., Bragado R., Palomero M. I., Bernabeu C., Vega M. A., Corbi A. L.: Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood, 2011;117:5092-5101
72. Sieve A. N., Meeks K. D., Lee S., Berg R. E.: A novel immunoregulatory function for IL-23: inhibition of IL-12-dependent IFN-γ production. Eur. J. Immunol., 2010;40:2236-2247
73. Silberman D., Bucknum A., Kozlowski M., Matlack R., Riggs J.: Cytokine treatment of macrophage suppression of T cell activation. Immunobiology, 2010;215:70-80
74. Silva Costa V., Colvara Mattana T. C., Rossi da Silva M. E.: Unregulated IL-23/IL-17 immune response in autoimmune diseases. Diabetes Res. Clin. Pract., 2010;88:222-226
75. Silverman J. M., Reiner N. E.: Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes. Cell. Microbiol., 2011;13:1-9
76. Stout R. D., Watkins S. K., Suttles J.: Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J. Leukoc. Biol., 2009;86:1105-1109
77. Svensson J., Jenmalm M. C., Matussek A., Geffers R., Berg G., Ernerudh J.: Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. J. Immunol., 2011;187:3671-3682
78. Tiemessen M. M., Jagger A. L., Evans H. G., van Herwijnen M. J., John S., Taams L. S.: CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA, 2007;104:19446-19451
79. Tuckermann J. P., Kleiman A., Moriggl R., Spanbroek R., Neumann A., Illing A., Clausen B. E., Stride B., Förster I., Habenicht A. J., Reichardt H. M., Tronche F., Schmid W., Schütz G.: Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J. Clin. Invest., 2007;117:1381-1390
80. Ulmann L., Hirbec H., Rassendren F.: P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J., 2010;29:2290-2300
81. Vergati M., Schlom J., Tsang K. Y.: The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring. J. Biomed. Biotechnol., 2011;2011:182413
82. Villalonga N., David M., Bielanska J., Vicente R., Comes N., Valenzuela C., Felipe A.: Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences. J. Gen. Physiol., 2010;135:135-147
83. Weiss J. M., Ridnour L. A., Back T., Hussain S. P., He P., Maciag A. E., Keefer L. K., Murphy W. J., Harris C. C., Wink D. A., Wiltrout R. H.: Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J. Exp. Med., 2010;207:2455-2467
84. Wentworth J. M., Naselli G., Brown W. A., Doyle L., Phipson B., Smyth G. K., Wabitsch M., O'Brien P. E., Harrison L. C.: Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes, 2010;59:1648-1656
85. Zamarron B. F., Chen W.: Dual roles of immune cells and their factors in cancer development and progression. Int. J. Biol. Sci., 2011;7:651-658
86. Zelkha S. A., Freilich R. W., Amar S.: Periodontal innate immune mechanisms relevant to atherosclerosis and obesity. Periodontol. 2000, 2010;54:207-221
87. Zhang X., Yu S., Hoffmann K., Yu K., Förster R.: Neonatal lymph node stromal cells drive myelo-dendritic lineage cells into a distinct population of CX3CR1+CD11b+F4/80+ regulatory macrophages. Blood, 2012;119:3975-3986
88. Zhou Q., Leeman S. E., Amar S.: Signaling mechanisms involved in altered function of macrophages from diet-induced obese mice affect immune responses. Proc. Natl. Acad. Sci. USA, 2009;106:10740-10745
89. Zingarelli B., Fan H., Ashton S., Piraino G., Mangeshkar P., Cook J. A.: Peroxisome proliferator activated receptor γ is not necessary for the development of LPS-induced tolerance in macrophages. Immunology, 2008;124:51-57
90. Zorzanelli Rocha V., Folco E. J.: Inflammatory concepts of obesity. Int. J. Inflamm., 2011;2011:529061